IL13RA2 and familial pancreatic carcinoma: These results are consistent with the findings of Kawakami et al.49 in that the overexpression of IL-13Rα2 proteins did not confer an added growth advantage in human breast and pancreatic cancer cell lines lacking the EGFRvIII receptors.